Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era.
Diseases
; 11(3)2023 Sep 18.
Article
in En
| MEDLINE
| ID: mdl-37754319
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Diseases
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: